1. Home
  2. JAZZ vs CIGI Comparison

JAZZ vs CIGI Comparison

Compare JAZZ & CIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAZZ
  • CIGI
  • Stock Information
  • Founded
  • JAZZ 2003
  • CIGI 1972
  • Country
  • JAZZ Ireland
  • CIGI Canada
  • Employees
  • JAZZ N/A
  • CIGI N/A
  • Industry
  • JAZZ Biotechnology: Pharmaceutical Preparations
  • CIGI
  • Sector
  • JAZZ Health Care
  • CIGI
  • Exchange
  • JAZZ Nasdaq
  • CIGI Nasdaq
  • Market Cap
  • JAZZ 8.2B
  • CIGI 7.7B
  • IPO Year
  • JAZZ 2007
  • CIGI N/A
  • Fundamental
  • Price
  • JAZZ $138.54
  • CIGI $167.78
  • Analyst Decision
  • JAZZ Strong Buy
  • CIGI Buy
  • Analyst Count
  • JAZZ 14
  • CIGI 7
  • Target Price
  • JAZZ $180.14
  • CIGI $175.00
  • AVG Volume (30 Days)
  • JAZZ 670.8K
  • CIGI 94.7K
  • Earning Date
  • JAZZ 11-05-2025
  • CIGI 11-04-2025
  • Dividend Yield
  • JAZZ N/A
  • CIGI 0.18%
  • EPS Growth
  • JAZZ N/A
  • CIGI N/A
  • EPS
  • JAZZ N/A
  • CIGI 2.21
  • Revenue
  • JAZZ $4,086,695,000.00
  • CIGI $5,169,495,000.00
  • Revenue This Year
  • JAZZ $5.70
  • CIGI $16.18
  • Revenue Next Year
  • JAZZ $6.16
  • CIGI $7.46
  • P/E Ratio
  • JAZZ N/A
  • CIGI $73.70
  • Revenue Growth
  • JAZZ 4.52
  • CIGI 16.63
  • 52 Week Low
  • JAZZ $95.49
  • CIGI $100.86
  • 52 Week High
  • JAZZ $148.06
  • CIGI $170.65
  • Technical
  • Relative Strength Index (RSI)
  • JAZZ 62.66
  • CIGI 70.35
  • Support Level
  • JAZZ $134.09
  • CIGI $153.53
  • Resistance Level
  • JAZZ $139.75
  • CIGI $154.09
  • Average True Range (ATR)
  • JAZZ 3.08
  • CIGI 3.01
  • MACD
  • JAZZ -0.21
  • CIGI 1.69
  • Stochastic Oscillator
  • JAZZ 83.51
  • CIGI 88.33

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About CIGI Colliers International Group Inc. Subordinate Voting Shares

Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.

Share on Social Networks: